BFB Health Income Statement

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	33.12	30.15	38.38	73.16	68.35
Revenue Growth (YoY)	9.84%	-21.44%	-47.54%	7.04%	-14.74%
Cost of Revenue	16.88	17.74	27.15	31.92	26.69
Gross Profit	16.23	12.42	11.23	41.24	41.66
Selling, General & Admin	19.82	24.79	47.89	25.14	28.95
Operating Expenses	32.1	49.97	45.7	25.14	28.95
Operating Income	-15.87	-37.55	-34.47	16.1	12.71
Interest Expense	-2.01	-1.92	-1.86	-1.68	-2.3
Interest & Investment Income	-	0.08	0.45	0.2	0.01
Earnings From Equity Investments	1.7	-22.53	-5.27	-2.71	-11.59
Currency Exchange Gain (Loss)	-0.22	2.12	2.69	16.15	-7.18
Other Non Operating Income (Expenses)	-3.68	-6.85	-6.15	2.47	1.47
EBT Excluding Unusual Items	-20.08	-66.65	-44.61	30.53	-6.87
Gain (Loss) on Sale of Investments	44.8	9.91	12.12	-118.04	-36.67
Gain (Loss) on Sale of Assets	-0.04	7.12	17.57	-0.1	-
Asset Writedown	-	-9.53	-	-	-
Other Unusual Items	-44.25	29.74	-25.55	0.32	-
Pretax Income	-19.57	-29.4	-40.47	-87.29	-43.54
Income Tax Expense	0.43	-0.52	-3.07	1.97	1.05
Earnings From Continuing Operations	-19.99	-28.88	-37.4	-89.26	-44.59
Minority Interest in Earnings	14.45	-5.71	14.12	6.79	4.46
Net Income	-5.54	-34.6	-23.28	-82.47	-40.14
Net Income to Common	-5.54	-34.6	-23.28	-82.47	-40.14
Shares Outstanding (Basic)	947	736	736	656	511
Shares Outstanding (Diluted)	958	736	736	656	511
Shares Change (YoY)	30.20%	-	12.23%	28.26%	46.81%
EPS (Basic)	-0.01	-0.05	-0.03	-0.13	-0.08
EPS (Diluted)	-0.01	-0.05	-0.03	-0.13	-0.08
Free Cash Flow	-	22.95	-36.8	-7.83	-22.85
Free Cash Flow Per Share	-	0.03	-0.05	-0.01	-0.04
Gross Margin	49.02%	41.18%	29.26%	56.37%	60.95%
Operating Margin	-47.92%	-124.55%	-89.82%	22.01%	18.59%
Profit Margin	-16.73%	-114.74%	-60.66%	-112.73%	-58.72%
Free Cash Flow Margin	-	76.13%	-95.89%	-10.70%	-33.43%
EBITDA	-15.57	-37.25	-34.21	16.54	13.58
EBITDA Margin	-47.00%	-123.54%	-89.14%	22.61%	19.86%
D&A For EBITDA	0.3	0.3	0.26	0.44	0.87
EBIT	-15.87	-37.55	-34.47	16.1	12.71
EBIT Margin	-47.92%	-124.55%	-89.82%	22.01%	18.59%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.